Comments
Loading...

Pacira BioSciences Earnings Estimates

PCRXNASDAQ
Logo brought to you by Benzinga Data
Q4 2024 Earnings were released on Thu Feb 27th, after the market close
The most recent conference call was at 16:30 PM, 6 days ago Click to view past webcast
GQ Bio Therapeutics GmbH announced it will be acquired by Pacira BioSciences (PCRX) on Thursday, February 27, 2025 for $32.0M

Pacira BioSciences Earnings Estimates, EPS & Revenue | NASDAQ:PCRX | Benzinga

Pacira BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 6
EPS Estimate
$0.750
Quarterly Revenue Estimate
$170.68M
Annual Revenue
(as of Dec 31)
$700.97M

Analyze the earnings history of Pacira BioSciences using advanced sorting and filters.

Data brought to you by Benzinga APIs

Pacira BioSciences (PCRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q42025-02-27$0.91$0.839.64 %
Q32024-11-06$0.79$0.7012.9 %
Q22024-07-30$0.89$0.7027.1 %
Q12024-05-07$0.62$0.620.00 %

Pacira BioSciences (PCRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q42025-02-27$187.25M$185.38M1.01 %
Q32024-11-06$168.57M$169.67M-0.65 %
Q22024-07-30$178.02M$172.48M3.21 %
Q12024-05-07$167.12M$165.35M1.07 %

FAQ

Q

When is Pacira BioSciences (NASDAQ:PCRX) reporting earnings?

A

Pacira BioSciences (PCRX) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.

Q

What were the latest earnings per share (EPS) for Pacira BioSciences (NASDAQ:PCRX)?

A

The Actual EPS was $0.91, which beat the estimate of $0.83.

Q

What were Pacira BioSciences’s (NASDAQ:PCRX) revenues?

A

The Actual Revenue was $187.3M, which beat the estimate of $185.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch